Literature DB >> 11139347

Pathophysiology, diagnosis and treatment of ascites in cirrhosis.

J Uriz1, A Cárdenas, V Arroyo.   

Abstract

Ascites is the most common complication of patients with cirrhosis; its development constitutes the first and most important manifestation of the disease and is an indication for liver transplantation. During the last decade significant advances have been made in regard to the pathogenesis and treatment of ascites. The description of a new hypothesis, the identification of new vasoactive factors involved in the pathogenesis of arterial vasodilation and the introduction of different therapeutic modalities (therapeutic paracentesis, transjugular intrahepatic portosystemic shunt, aquaretics drugs and liver transplantation) are all proof of this. Similarly, the description of predictive factors for the survival of patients with cirrhosis has been of major importance for the identification of candidates for liver transplantation. This chapter reviews current knowledge on the pathophysiology, diagnosis and treatment of ascites in patients with cirrhosis. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11139347     DOI: 10.1053/bega.2000.0139

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Gastroenterol


  5 in total

1.  The role of ascitic fluid viscosity in the differential diagnosis of ascites.

Authors:  Huseyin Savas Gokturk; Mehmet Demir; Nevin Akcaer Ozturk; Gulhan Kanat Unler; Sevsen Kulaksizoglu; Ilknur Kozanoglu; Ender Serin; Ugur Yilmaz
Journal:  Can J Gastroenterol       Date:  2010-04       Impact factor: 3.522

2.  Coughing may lead to spontaneous chylothorax and chylous ascites.

Authors:  Gokhan Adas; Oguzhan Karatepe; Muharrem Battal; Yasar Dogan; Savas Karyagar; Asim Kutlu
Journal:  Case Rep Gastroenterol       Date:  2007-12-31

Review 3.  Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment.

Authors:  Richa Bhardwaj; Haleh Vaziri; Arun Gautam; Enrique Ballesteros; David Karimeddini; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2017-12-04

4.  Qi Sui Zhu Shui Plaster Inhibits AQP1 and MAPK Signaling Reduces Liver Damage Induced by Cirrhotic Ascites.

Authors:  Rong Zhen Zhang; Yin Liu; Min Li; Yong Lin Huang; Zhen Heng Song
Journal:  J Healthc Eng       Date:  2022-03-30       Impact factor: 2.682

Review 5.  Chylous Ascites: Evaluation and Management.

Authors:  Said A Al-Busafi; Peter Ghali; Marc Deschênes; Philip Wong
Journal:  ISRN Hepatol       Date:  2014-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.